Endocrinology and Metabolism | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, Jessica
Cipriani, Cristiana
Cantatore, F. P
Fabbri, A
Pola, E
Vinicola, V
Raimo, Orlando
Biamonte, Federica
Pascone, Roberto
Ferrara, Carla
Minisola, Salvatore

January 2017

Purpose To investigate the effect of 18 months’ para- thyroid hormone 1–84 (PTH 1–84) ...

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

F. Vescini
R. Attanasio
A. Balestrieri
F. Bandeira
S. Bonadonna
V. Camozzi
S. Cassibba
R. Cesareo
I. Chiodini
C.M. Francucci
L. Gianotti
F. Grimaldi
R. Guglielmi
B. Madeo
C. Marcocci
A. Palermo
A. Scillitani
E. Vignali
V. Rochira
M. Zini

January 2016

Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone ...

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women

Esteban J&oacute

April 2007

Esteban Jódar-GimenoEndocrinology and Metabolism Service, University Hospital “12 de Oc...

Parathyroid Hormone in Osteoporosis Treatment

İ. Özkul

March 2002

Parathyroid hormone stimulates bone formation, prevents or reverses bone loss, increases bone mass, ...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
Cipriani, C
Cantatore, F P
Fabbri, A
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S

January 2017

Purpose To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on ser...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
Cipriani, C
Cantatore, F P
Fabbri, A
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S

January 2017

Purpose To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on ser...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, Jessica
Cipriani, Cristiana
Cantatore, F. P
Fabbri, A
Pola, E
Vinicola, V
Raimo, Orlando
Biamonte, Federica
Pascone, Roberto
Ferrara, Carla
Minisola, Salvatore

January 2017

Purpose To investigate the effect of 18 months’ para- thyroid hormone 1–84 (PTH 1–84) ...

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

F. Vescini
R. Attanasio
A. Balestrieri
F. Bandeira
S. Bonadonna
V. Camozzi
S. Cassibba
R. Cesareo
I. Chiodini
C.M. Francucci
L. Gianotti
F. Grimaldi
R. Guglielmi
B. Madeo
C. Marcocci
A. Palermo
A. Scillitani
E. Vignali
V. Rochira
M. Zini

January 2016

Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone ...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
CIPRIANI, CHIARA
Cantatore, Fp
FABBRI, ANDREA
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S.

February 2017

To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
Cipriani, C
Cantatore, F P
Fabbri, A
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S

January 2017

Purpose To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on ser...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, J
Cipriani, C
Cantatore, F P
Fabbri, A
Pola, E
Vinicola, V
Raimo, O
Biamonte, F
Pascone, R
Ferrara, C
Minisola, S

January 2017

Purpose To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on ser...

The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis

Pepe, Jessica
Cipriani, Cristiana
Cantatore, F. P
Fabbri, A
Pola, E
Vinicola, V
Raimo, Orlando
Biamonte, Federica
Pascone, Roberto
Ferrara, Carla
Minisola, Salvatore

January 2017

Purpose To investigate the effect of 18 months’ para- thyroid hormone 1–84 (PTH 1–84) ...

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

F. Vescini
R. Attanasio
A. Balestrieri
F. Bandeira
S. Bonadonna
V. Camozzi
S. Cassibba
R. Cesareo
I. Chiodini
C.M. Francucci
L. Gianotti
F. Grimaldi
R. Guglielmi
B. Madeo
C. Marcocci
A. Palermo
A. Scillitani
E. Vignali
V. Rochira
M. Zini

January 2016

Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone ...